NuVasive Inc
F:NK8
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
N
|
NuVasive Inc
F:NK8
|
1.9B EUR |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
184.5B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.3B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
136.2B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.2B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
129B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.4B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.3B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.8B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.4B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
NuVasive Inc
Glance View
In the ever-evolving world of healthcare innovation, NuVasive Inc. stands as a noteworthy beacon in the field of spinal surgery technology. Founded in 1997 and based in San Diego, California, the company has carved a niche for itself with its minimally invasive surgical procedures designed to transform spinal care. The cornerstone of its success lies in its proprietary Maximum Access Surgery (MAS) platform, which reduces operating time and recovery periods for patients undergoing spinal procedures. By integrating its cutting-edge surgical solutions with advanced neuromonitoring technology and a comprehensive suite of procedural systems, NuVasive aids surgeons in executing complex operations with precision and efficiency. This unique amalgamation of technology and medical expertise not only enhances surgical outcomes but also has cemented NuVasive’s reputation as a leader in less-invasive spinal surgery. Financially, NuVasive harnesses an effective business model that generates revenue through the sale of its specialized surgical equipment, including implants and biologics, as well as through service offerings like its intraoperative monitoring services. The company's revenue streams are largely driven by product sales directly to hospitals and surgical centers, where innovative tools and technologies are in high demand. As healthcare facilities increasingly seek advanced methods to improve patient outcomes and operating efficiencies, NuVasive finds itself at the forefront of this demand, continuously expanding its product portfolio and global reach. By investing heavily in research and development, the company ensures its products stay at the cutting edge of medical technology, providing not just immediate financial growth, but also a long-term strategic advantage in the global market for spinal surgery solutions.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for NuVasive Inc is 2.7%, which is above its 3-year median of 2.6%.
Over the last 3 years, NuVasive Inc’s Net Margin has increased from -0.4% to 2.7%. During this period, it reached a low of -6.4% on Dec 31, 2021 and a high of 3.6% on Dec 31, 2022.